Eli Lilly (LLY) Gets a Big Price Target Boost, Analysts See 20% Upside

On September 15, Berenberg upgraded its rating on Eli Lilly and Company (NYSE:LLY) from Hold to Buy and lifted its price target from $1,220 to $1,400.
The research firm pointed to the company's strong returns on investment and its growth in
Read more...